Skip to main content

Closed

ELTX: Elicio Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-227.7%

Financially safe

Stretched

Debt / equity-9.98×

Interest coverage-27.6×

Current ratio2.24×

Elicio Therapeutics, Inc.

ELTXNASDAQ Global Market·USD·Closed

Elicio Therapeutics, Inc.

ELTXNASDAQ·USD·Closed

$2.80

−3.78%

$2.80

−$0.11 (3.78%)

52W Range

1thpctl

Volume

0.24×avg

Mkt Cap

53.39MUSD

P/E

-1.2TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.24×avg

Market Cap

53.39MUSD

P/E Ratio

-1.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings